四川泰恩康制药有限公司

四川泰恩康制药有限公司

四川省广安市岳池经济开发区健康路22号

2020

250至299

不愿意公开

四川泰恩康制药有限公司，成立于2020年，为广东泰恩康医药股份有限公司(股票代码：301263）的控股子公司，是一家以仿制药原料药及中间体的研发、生产与销售为一体的制药公司。泰恩康专注于生产盐酸达泊西汀、他达拉非等独具特色且高附加值的各类原料药和高级中间体，可满足市场的多样化需求。四川泰恩康工厂坐落于四川省岳池经济开发区省级化工园区内，占地面积达100亩，是一座现代化的医药生产基地。工厂计划建设6栋生产车间，目前一期工程已建成，包括4条独立生产线和1个D级GMP车间。车间配备了500L-5000L的多功能反应釜，能够承接各种复杂的化学反应，契合客户从中试到验证再到商业化生产的全方位需求。泰恩康医药股份拥有三大研发基地，汇聚了近200名研发精英，其中博士、硕士人才比例达20%。研发团队实力强劲、经验丰富，擅长工艺优化，降低成本，迅速响应市场变化，确保公司竞争优势。此外，公司还拥有一支专业的质量管理团队和一流的设备仪器，致力于为客户提供符合国内外注册申报要求的原料药、中间体的质量研究和稳定性研究服务。从分析方法的开发、优化、验证、转移到质量标准的研究，再到稳定性研究和产品放行测试，公司均能提供全方位的解决方案。泰恩康的质量管理体系严格遵循中国、欧美、日本国际cGMP标准，力保每一批产品都达到最高品质。公司注册团队拥有丰富的中、外注册申报经验，能够为客户提供高效、专业的服务。我们坚信，四川泰恩康将以卓越的品质和专业的服务，赢得更多客户的信赖和支持，成为制药领域的佼佼者。

品牌,国际认证/标准,经验丰富的研发人员,发货速度,生产能力,产品线丰富,接受买家的规格要求,接受小额订单,良好的信誉,优质服务

638300

制造商

中国,北美洲,中/南美洲,西欧,东欧,中东,亚洲

Acalabrutinib（1420477-60-6）;Avibactam（1192491-61-4）;Belzutifan（1672668-24-4);Deucravacitinib（1609392-27-9）;Eluxadoline（864821-90-9）;Encorafenib（1269440-17-6）;Lumateperone（1187020-80-9）;Neratinib maleate（915942-22-2）;Ribociclib（1374639-75-4）;Rucaparib camsylate（1859053-21-6）;Siponimod（1230487-00-9）;Trilaciclib（1977495-97-8）;Elacestrant（1349723-93-8）;Zavegepant（1337918-83-8）;Berotralstat（1809010-50-1）;Ozanimod（1306760-87-1）;(3-chloropyrazin-2-yl)methanamine hydrochloride (939412-86-9);(S)-benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate (1420478-88-1);4-(pyridin-2-yl-aminocarbonyl)benzeneboronic acid (850568-25-1);N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide (1383385-64-5);(2S,5R)-Ethyl-5-[(benzyloxy)amino]piperidine-2-carboxylate ethanedioate (1:1) (1416134-48-9);(2S,5R)-5-[(benzyloxy)amino]piperidine-2-carboxamide (1416134-49-0);Avibactam tetrabutylammonium salt (1192651-80-1);4-fluoro-7-(methylsulfonyl)-2,3-dihydro-1H-inden-1-one (1672665-29-0);3-fluoro-5-((7-(methylsulfonyl)-1-oxo-2,3-dihydro-1H-inden-4-yl)oxy)benzonitrile (1672665-55-2);2-Methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline (1609394-10-6);ethyl 4,6-dihydroxypyridazine-3-carboxylate (1352925-63-3);Ethyl 4,6-dichloro-3-pyridazinecarboxylate (679406-03-2);(S)-2-(tert-butoxycarbonylaMino)-3-(4-carbaMoyl-2,6-diMethylphenyl)propanoic acid (623950-02-7);Methyl 5-formyl-2-methoxybenzoate (78515-16-9);(S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine (864825-23-0);(S)-Methyl 2-Methoxy-5-((1-(4-phenyl-1H-imidazol-2-yl)ethylamino)methyl)benzoate (1391712-57-4);tert-butyl (5-chloro-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate (1269440-69-8);2-chloro-4-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)pyrimidine (1269440-58-5);(S)-Methyl 1-aminopropan-2-ylcarbamate hydrochloride (1229025-32-4);[4aS,9bR]-6-bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole S-mandelate (1059630-13-5);(6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate (313369-25-4);(6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline (313368-85-3);N-(4-chloro-3-cyano-7-ethoxy-1,4-dihydroquinolin-6-yl)acetamide (848133-76-6);4-((pyridin-2-yl)methoxy)-3-chlorobenzenamine (524955-09-7);4-(6-Aminopyridin-3-yl)piperazine-1-carboxylic acid tert-butyl ester (571188-59-5);2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid (1211443-58-1);2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide (1211443-61-6);methyl 6-fluoro-1H-indole-4-carboxylate (1082040-43-4);8-fluoro-3,4-dihydro-2H-azepino[5,4,3-cd]indol-1(6H)-one (1408282-26-7);5-bromo-8-fluoro-3,4-dihydro-2H-azepino[5,4,3-cd]indol-1(6H)-one (283173-80-8);(4-cyclohexyl-3-(trifluoromethyl)phenyl)methanol (957205-23-1);4-(bromomethyl)-1-cyclohexyl-2-(trifluoromethyl)benzene (800381-60-6);1-(3-ethyl-4-hydroxymethylphenyl)ethanone (1378888-43-7);(E)-4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzaldehyde (1230487-01-0);O-[4-cyclohexyl-3-(trifluoromethyl)benzyl]hydroxylamine (800379-62-8);tert-butyl ((1-aminocyclohexyl)methyl)carbamate (1352999-04-2);tert-butyl ((1-((5-bromo-2-chloropyrimidin-4-yl)amino)cyclohexyl)methyl)carbamate (1374635-87-6);5-(4-methyl-piperazin-1-yl)pyridin-2-ylamine (571189-49-6);1,4-diazaspiro[5,5]undecan-3-one (1547757-91-4);methyl 1-methoxy-4-oxocyclohexane-1-carboxylate (1622928-67-9);(S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethan-1-amine (1980023-96-8);Cyclohexanecarboxylic acid, 4-(1,6-dihydro-4-methyl-6-oxo-2-pyrimidinyl)-1-methoxy-, methyl ester, cis- (2778223-48-4);3-(5-hydroxypyrimidin-2-yl)benzoic acid (1092568-86-9);3-(6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile (52240-08-1);tert-butyl 4-(hydroxymethyl)piperidine-1-carboxylate (123855-51-6);3-Bromo-1,2-dihydro-7-(phenylmethoxy)naphthalene (722536-73-4);2-(4-formylphenyl)acetic acid (34841-47-9);6-(2-Amino-4-methoxyphenyl)-5,6,7,8-tetrahydro-2-naphthalenol (722520-36-7);4-Methoxy-2-nitrophenylboronic acid (860034-09-9);(R)-2-amino-3-(7-methyl-1H-indazol-5-yl)propanoic acid dihydrochloride (1414976-15-0);3-(7-methyl-1H-indazol-5-yl)-2-oxopropanoic acid (868707-31-7);3-(Piperidin-4-yl)quinolin-2(1H)-one hydrochloride (855778-84-6);1-(1-Methylpiperidin-4-yl)piperazine trihydrochloride (349535-15-5);Benzonitrile, 3-[[(3R)-2,3-dihydro-3-hydroxy-7-(methylsulfonyl)-1-oxo-1H-inden-4-yl]oxy]-5-fluoro- (2738675-96-0);[(cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-3-Pyridazinecarboxylic acid zinc salt (2:1) (2245111-19-5);(6bR,10aS)-2,3,6b,7,8,9,10,10a-Octahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline dihydrochloride (2339905-28-9);(6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate HCl (313369-26-5);Ozanimod (1618636-37-5);2,3-dihydro-1-oxo-1H-indene-4-carbonitrile (60899-34-5);(S)-1-amino-2,3-dihydro-1H-indene-4-carbonitrile hydrogen chloride (1306763-57-4);Suzetrigine;Avapritinib;Baloxavir marboxil;Belumosudil mesylate;Capivasertib;Polidocanol;Lauromacrogol 400;Momelotinib;Nirogacestat;Obicetrapib;Olutasidenib;Orforglipron;Pimavanserin tartrate;Pemigatinib;Pirtobrutinib;Rogaratinib;Semaglutide side chain;Tauroursodeoxycholic acid;Tovorafenib;Vericiguat;Xanomeline;Berberine hydrochloride;Boceprevir;Cobicistat;Doravirine;Dyclonine HCl;Elexacaftor;Gilteritinib;Lazertinib;Idasanutlin;Osilodrostat Phosphate;Rilzabrutinib;Zidebactam;Semaglutide;Romiplostim;Ranibizumab;Insulin icodec;CAS: 298689-75-5;CAS: 1188083-45-5;CAS: 2089246-64-8;CAS: 2764851-03-6;CAS: 1095824-76-2;CAS: 1095824-77-3;CAS: 914916-98-6;CAS: 1956437-47-0;CAS: 131986-59-9;CAS: 131986-28-2;CAS: 131987-69-4;CAS: 131988-19-7;CAS: 1254058-34-8;CAS: 2043020-03-5;CAS: 313340-08-8;CAS: 886061-26-3;CAS: 956460-98-3;CAS: 252720-31-3;CAS: 479064-90-9  ;CAS: 2649470-89-1;CAS: 2649470-87-9;CAS: 2649469-37-2;CAS: 2875067-17-5;CAS: 888721-83-3;CAS: 1703794-33-5;CAS: 1704492-14-7;CAS: 1703794-73-3;CAS: 1903009-55-1;CAS: 2438331-81-6;CAS: 2270944-70-0;CAS: 1903010-39-8;CAS: 1213536-98-1;CAS: 2097878-69-6;CAS: 865774-26-1;CAS: 952582-02-4;CAS: 769132-28-7;CAS: 952582-00-2;CAS: 20028-53-9;CAS: 327056-62-2;CAS: 1887009-48-4;CAS: 1887015-55-5;CAS: 2212021-61-7;CAS: 1784678-61-0;CAS: 2212021-59-3;CAS: 2212021-79-7;CAS: 127607-62-9;CAS: 928136-82-7;CAS: 928134-37-6

第二十三届世界制药原料中国展

2025-03-06至2025-07-31

E6D53

Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;CMO & CRO